Selected Publications
Takeshi Onoue, Andrew H Matthews, Azin Vakilpour, Yu Kang, Bénédicte Lefebvre, Amanda M Smith, Shannon R McCurdy, Michael G Fradley, Joseph Carver, Jesse Chittams, Marielle Scherrer-Crosbie: Cardiotoxicity of venetoclax in patients with acute myeloid leukemia: comparison with anthracyclines Cardio-Oncology 10 (1): 2024.
Matthew P Connor, Neeharika Prathapa, Noelle V Frey, Saar I Gill, Elizabeth O Hexner, Ximena Jordan Bruno, Catherine E Lai, Alison W Loren, Selina M Luger, Andrew H Matthews, Shannon R McCurdy, Alexander E Perl, David L Porter, Arlene Zeringue, Joseph H Oved, Timothy S Olson, Keith W Pratz, Daria V Babushok: Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia Haematologica 8 (109): 2732-2737,2024.
Laczko D, Poveda-Rogers C, Matthews AH, Snaith O, Luger S, Bagg A, Caponetti GC, Morrissette JJD, Yang G.: RAD21 mutations in acute myeloid leukemia Leuk & Lymphoma : 2024.
Matthews A, Fenu E, Skuli SJ, Harris JC, Lai C.: Immunohistochemistry-based detection of TP53 mutations in acute myeloid leukemia: a promising high sensitivity diagnostic approach. Leuk & Lymphoma : 2024.
Abaza Y, Winer ES, Murthy GSG, Shallis RM, Matthews AH, Badar T, Geramita EM, Kota VK, Swaroop A, Doukas P, Bradshaw D, Helenowski IB, Liu Y, Zhang H, Im A, Litzow MR, Perl AE, Atallah E, Altman JK.: Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real‐world data from eight US academic centers Am J Hematol 99 (4): 2024.
Matthews AH, Perl AE, Luger SM, Gill SI, Lai C, Porter DL, Skuli S, Bruno XJ, Carroll MP, Freyer CW, Carulli A, Babushok DV, Frey NV, Hexner EO, Martin ME, McCurdy SR, Stadtmauer EA, Loren AW, Paralkar VR, Maillard IP, Pratz KW.: Real-world effectiveness of intensive chemotherapy with 7&3 versus venetoclax and hypomethylating agent in acute myeloid leukemia Am J Hematol : 2023.
Matthews AH, Perl AE, Luger SM, Loren AW, Gill SI, Porter DL, Babushok DV, Maillard I, Carroll MP, Frey NV, Hexner E, Martin ME, McCurdy SR, Stadtmauer EA, Paralkar VR, Jordan Bruno X, Hwang WT, Margolis D, Pratz KW.: Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia. Blood Adv
6 (13): 3997-4005,2022.
Matthews AH, Yui J, Chiang EY, Pishko AM, Cuker A, Cucchiara BL, George D, Sayani F, Mullen MT.: Cerebral Infarction due to Severe ADAMTS-13 Deficiency with Normal Hematological Parameters: A Potential Cause of Cryptogenic Stroke. J Stroke Cerebrovasc Dis. J Stroke Cerebrovasc Dis 31 (6): 106431,2022.
Halaby R, Cuker A, Yui J, Matthews AH, Ishaaya E, Traxler E, Domenico C, Cooper T, Tierney A, Niami P, van der Rijst N, Adusumalli S, Gutsche J, Giri J, Pugliese S, Hecht TEH, Pishko AM.: Bleeding Risk by Intensity of Anticoagulation in Critically Ill Patients with COVID-19: A Retrospective Cohort Study. J Thromb Haemost
19 (6): 1533-1545,2021.
Berwick S, Hila C, Matthews AH, Mukhopadhyay A, Poole B, Talan J, Hayes M, Smith C.: “Frequency and Impact of Gender-Biased Professional Misidentification of Resident Physicians.” Academic Medicine. Acad Med
96 (6): 869-875,2021.
Academic Contact Information
Perelman Center for Advanced Medicine
12 South Pavilion
Philadelphia,
PA
19104